Table 4 Breakdown of costs used in the economic analysis
Item | Code | Cost | Reference | Assumption |
|---|---|---|---|---|
Radical excision | MB01B | £1971 | UKGOSOC data | 3.86 (s.e.=7.75) bed days (range 1–10), administered on its own in the case of a cancer recurrence: see assumptions in appendix |
IFL (+radical excision) | MA06Z | £4129 | UKGOSOC data | 5.64 (s.e.=9.09) bed days (range 2–11) |
Radiotherapy | SC22Z+ SC56Z | £1728 | NHS reference costs | ‘3 Weeks of treatment, 5 days each week (assumption) |
Chemotherapy | SB12Z+SB15Z | £1270 | NHS reference costs | ‘Inpatient’ assume drugs from regime in band 6 Procurement+Delivery £779+£207+£284 |
Monitoring of patients | 503 | £171 | NHS reference costs | Per/consultation. Undertaken every 2 months for SLN pathways no. 2–7 (=12 times over 2 years), every 3 months for IFL no. 1 pathway (=8 times over 2 years) |
One bed day | MA06Z | £312 | NHS reference costs | |
SLN biopsy (+radical excision) | ||||
Blue dye | MA06Z | £3574 | NHS reference costs (UKGOSOC data for the bed days) | 3.86 (s.e.=7.75) bed days (range 1–10) |
99mTc | MA06Z+RA36Z | £3836 | NHS reference costs (UKGOSOC data for the bed days) | 3.86 (s.e.=7.75) bed days (range 1–10) |
Blue dye+99mTc | MA06Z+RA36Z | £4219 | NHS reference costs (UKGOSOC data for the bed days) | 3.86 (s.e.=7.75) bed days (range 1–10) |
Morbidity and mortality | ||||
Short term | MA06Z | £1635 | NHS reference costs | Mean=5.24 (s.e.=5.24 assumed) bed days (Selman, 2009) |
Long term | MA06Z. 502 gynaecology | £702 | NHS reference costs | 3 Outpatient visits+1 bed day (assumed) |
Vulval cancer-related death | SD01A | £436 | NHS reference costs | Specialist palliative care, inpatient |
Histopathology | ||||
Haematoxylin and eosin | £74.50 | Histology department, Birmingham City Hospital | ||
Ultrastaging | £86.75 | Histology department, Birmingham City Hospital | ||
